QQ客服 官方微博 反馈留言

	Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
	Wang, Guogan; Wang, Pengbo; Li, Yishi; Liu, Wenxian; Bai, Shugong; Zhen, Yang; Li, Dongye; Yang, Ping; Chen, Yu; Hong, Lang
刊名	MEDICINE
	2016
卷号	95期号:9
ISSN号	0025-7974
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3515261
专题	吉林大学白求恩第三医院
推荐引用方式 GB/T 7714	Wang, Guogan,Wang, Pengbo,Li, Yishi,et al. Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial[J]. MEDICINE,2016,95(9).
APA	Wang, Guogan.,Wang, Pengbo.,Li, Yishi.,Liu, Wenxian.,Bai, Shugong.,...&Wang, Sijia.(2016).Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.MEDICINE,95(9).
MLA	Wang, Guogan,et al."Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial".MEDICINE 95.9(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。